Annual ROE
-157.13%
-82.06%-109.31%
December 31, 2023
Summary
- As of February 12, 2025, BPMC annual return on equity is -157.13%, with the most recent change of -82.06% (-109.31%) on December 31, 2023.
- During the last 3 years, BPMC annual ROE has fallen by -189.58% (-584.22%).
- BPMC annual ROE is now -111.24% below its all-time high of 1397.86%, reached on December 31, 2013.
Performance
BPMC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-50.13%
+30.44%+37.78%
September 30, 2024
Summary
- As of February 12, 2025, BPMC quarterly return on equity is -50.13%, with the most recent change of +30.44% (+37.78%) on September 30, 2024.
- Over the past year, BPMC quarterly ROE has increased by +83.02% (+62.35%).
- BPMC quarterly ROE is now -207.28% below its all-time high of 46.73%, reached on September 30, 2020.
Performance
BPMC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BPMC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -109.3% | +62.4% |
| 3 y3 years | -584.2% | +52.5% |
| 5 y5 years | -246.3% | +52.5% |
BPMC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -197.7% | at low | at high | +68.9% |
| 5 y | 5-year | -584.2% | at low | -207.3% | +68.9% |
| alltime | all time | -111.2% | at low | -207.3% | +68.9% |
Blueprint Medicines ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -50.13%(-37.8%) |
| Jun 2024 | - | -80.57%(-23.5%) |
| Mar 2024 | - | -105.27%(-34.7%) |
| Dec 2023 | -157.13%(+109.3%) | -161.12%(+21.0%) |
| Sep 2023 | - | -133.15%(+26.3%) |
| Jun 2023 | - | -105.43%(+16.1%) |
| Mar 2023 | - | -90.83%(+22.4%) |
| Dec 2022 | -75.07%(+42.2%) | -74.23%(-7.2%) |
| Sep 2022 | - | -79.95%(+18.0%) |
| Jun 2022 | - | -67.78%(+21.5%) |
| Mar 2022 | - | -55.79%(+11.2%) |
| Dec 2021 | -52.78%(-262.7%) | -50.19%(+65.2%) |
| Sep 2021 | - | -30.38%(-209.0%) |
| Jun 2021 | - | 27.88%(-6.4%) |
| Mar 2021 | - | 29.80%(-14.2%) |
| Dec 2020 | 32.45%(-141.2%) | 34.73%(-25.7%) |
| Sep 2020 | - | 46.73%(-167.1%) |
| Jun 2020 | - | -69.60%(-2.5%) |
| Mar 2020 | - | -71.37%(-4.1%) |
| Dec 2019 | -78.72% | -74.40%(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -76.57%(+8.0%) |
| Jun 2019 | - | -70.91%(+26.0%) |
| Mar 2019 | - | -56.28%(+26.3%) |
| Dec 2018 | -45.38%(+28.2%) | -44.55%(+11.9%) |
| Sep 2018 | - | -39.82%(+15.2%) |
| Jun 2018 | - | -34.58%(-17.9%) |
| Mar 2018 | - | -42.10%(-1.1%) |
| Dec 2017 | -35.39%(-12.9%) | -42.55%(-14.1%) |
| Sep 2017 | - | -49.56%(-1.8%) |
| Jun 2017 | - | -50.47%(-12.0%) |
| Mar 2017 | - | -57.32%(+10.2%) |
| Dec 2016 | -40.61%(-31.0%) | -52.01%(-0.0%) |
| Sep 2016 | - | -52.03%(+18.7%) |
| Jun 2016 | - | -43.85%(-3.2%) |
| Mar 2016 | - | -45.28%(-8.7%) |
| Dec 2015 | -58.83%(-48.3%) | -49.61%(-6.9%) |
| Sep 2015 | - | -53.28%(-17.6%) |
| Jun 2015 | - | -64.67%(-56.6%) |
| Mar 2015 | - | -149.06%(+31.1%) |
| Dec 2014 | -113.71%(-108.1%) | -113.71% |
| Dec 2013 | 1397.86% | - |
FAQ
- What is Blueprint Medicines annual return on equity?
- What is the all time high annual ROE for Blueprint Medicines?
- What is Blueprint Medicines annual ROE year-on-year change?
- What is Blueprint Medicines quarterly return on equity?
- What is the all time high quarterly ROE for Blueprint Medicines?
- What is Blueprint Medicines quarterly ROE year-on-year change?
What is Blueprint Medicines annual return on equity?
The current annual ROE of BPMC is -157.13%
What is the all time high annual ROE for Blueprint Medicines?
Blueprint Medicines all-time high annual return on equity is 1397.86%
What is Blueprint Medicines annual ROE year-on-year change?
Over the past year, BPMC annual return on equity has changed by -82.06% (-109.31%)
What is Blueprint Medicines quarterly return on equity?
The current quarterly ROE of BPMC is -50.13%
What is the all time high quarterly ROE for Blueprint Medicines?
Blueprint Medicines all-time high quarterly return on equity is 46.73%
What is Blueprint Medicines quarterly ROE year-on-year change?
Over the past year, BPMC quarterly return on equity has changed by +83.02% (+62.35%)